McDonald's Strategy: GLP-1 Boom as Menu Opportunity

McDonald's USA president Skye Anderson addressed investors on Wednesday, September 23, 2026, framing the GLP-1 weight-loss and diabetes medication boom as a strategic menu opportunity. Executive leadership noted that households with GLP-1 users represent active customer segments, while industry data highlights evolving consumer demand for smaller portions and lighter options.

### Tape / Session Read Industry analysis shows that quick-service restaurant spending among GLP-1 households fell by nearly 9% after six to eight months of usage, according to PwC data cited in market reports. Concurrently, one-third of these consumers seek smaller portions at lower prices, while 32% desire half-portions or split plates without additional upcharges.

### Why This Lane Matters Shifting consumer appetites driven by GLP-1 medications alter traditional fast-food demand patterns. Operators across the quick-service and casual dining sectors face mounting pressure to adapt portion tiers, pricing models, and menu architecture to retain weight-conscious patrons without disrupting baseline operations.

### Related Names No additional equity tickers were mentioned in the verified source text or tickers_mentioned list.